Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren(California Allergy and Asthma Medical Group), John G. Matthews(King's College London), Sofia Mosesova, Phillip E. Korenblat, Mark D. Eisner(Royal Victoria Infirmary), Joseph R. Arron(Rockefeller University), Heleen Scheerens, Jeffrey M. Harris, Sean P. Bohen, Zheng Su, Lawren C. Wu(PCR Oncology), Merdad V. Parsey(Pacific Biosciences (United States)), Robert F. Lemanske(University of Wisconsin–Madison), Nicola A. Hanania(Baylor College of Medicine)
Cited by 1,503
Related Papers
Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma
|New England Journal of Medicine|2006|1.1k
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2010|986
Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2002|898
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*
|Critical Care Medicine|2005|729
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma
|Journal of Allergy and Clinical Immunology|2005|591